Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prognostic value of cyclin B in endometrial endometrioid adenocarcinoma.
Santala S, Talvensaari-Mattila A, Soini Y, Santala M. Santala S, et al. Among authors: talvensaari mattila a. Tumour Biol. 2015 Feb;36(2):953-7. doi: 10.1007/s13277-014-2676-4. Epub 2014 Oct 15. Tumour Biol. 2015. PMID: 25315186
Combination of strong MMP-2 and weak TIMP-2 immunostainings is a significant prognostic factor in endometrial carcinoma.
Honkavuori-Toivola M, Santala M, Soini Y, Turpeenniemi-Hujanen T, Talvensaari-Mattila A. Honkavuori-Toivola M, et al. Among authors: talvensaari mattila a. Dis Markers. 2013;35(4):261-6. doi: 10.1155/2013/416870. Dis Markers. 2013. PMID: 24344400 Free PMC article.
Claudin-5 is associated with elevated TATI and CA125 levels in mucinous ovarian borderline tumors.
Nissi R, Talvensaari-Mattila A, Kuvaja P, Pääkkö P, Soini Y, Santala M. Nissi R, et al. Among authors: talvensaari mattila a. Anticancer Res. 2015 Feb;35(2):973-6. Anticancer Res. 2015. PMID: 25667483
Matrix metalloproteinase-2 (MMP-2) and -9 (MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in differential diagnosis between low malignant potential (LMP) and malignant ovarian tumours.
Määtta M, Talvensaari-Mattila A, Turpeenniemi-Hujanen T, Santala M. Määtta M, et al. Anticancer Res. 2007 Jul-Aug;27(4C):2753-8. Anticancer Res. 2007. PMID: 17695443
Cyclin E Expression Correlates with Cancer-specific Survival in Endometrial Endometrioid Adenocarcinoma.
Santala S, Talvensaari-Mattila A, Soini Y, Santala M. Santala S, et al. Among authors: talvensaari mattila a. Anticancer Res. 2015 Jun;35(6):3393-7. Anticancer Res. 2015. PMID: 26026100
High expression of cyclin A is associated with poor prognosis in endometrial endometrioid adenocarcinoma.
Santala S, Talvensaari-Mattila A, Soini Y, Honkavuori-Toivola M, Santala M. Santala S, et al. Among authors: talvensaari mattila a. Tumour Biol. 2014 Jun;35(6):5395-9. doi: 10.1007/s13277-014-1703-9. Epub 2014 Feb 12. Tumour Biol. 2014. PMID: 24519066
Immunoreactivity for TIMP-2 is associated with a favorable prognosis in endometrial carcinoma.
Honkavuori-Toivola M, Talvensaari-Mattila A, Soini Y, Turpeenniemi-Hujanen T, Santala M. Honkavuori-Toivola M, et al. Tumour Biol. 2012 Aug;33(4):935-41. doi: 10.1007/s13277-012-0321-7. Epub 2012 Jan 21. Tumour Biol. 2012. PMID: 22270451
Increased matrix metalloproteinases 2 and 9 and tissue inhibitor of matrix metalloproteinase 2 expression is associated with progression from vulvar intraepithelial neoplasia to invasive carcinoma.
Määttä M, Santala M, Soini Y, Turpeenniemi-Hujanen T, Talvensaari-Mattila A. Määttä M, et al. Acta Obstet Gynecol Scand. 2010 Mar;89(3):380-4. doi: 10.3109/00016340903555990. Acta Obstet Gynecol Scand. 2010. PMID: 20109015
High serum TIMP-1 is associated with adverse prognosis in endometrial carcinoma.
Honkavuori M, Talvensaari-Mattila A, Puistola U, Turpeenniemi-Hujanen T, Santala M. Honkavuori M, et al. Anticancer Res. 2008 Sep-Oct;28(5A):2715-9. Anticancer Res. 2008. PMID: 19035300
High preoperative plasma TIMP-1 is prognostic for early relapse in primary breast carcinoma.
Kuvaja P, Talvensaari-Mattila A, Turpeenniemi-Hujanen T. Kuvaja P, et al. Int J Cancer. 2008 Aug 15;123(4):846-51. doi: 10.1002/ijc.23531. Int J Cancer. 2008. PMID: 18506691
50 results
Jump to page
Feedback